Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVACFLU-S in healthy adults
NCT03095599Phase 3Completed
- Sponsor
- Institute of Vaccines and Medical Biologicals
- Start
- Mar 2017
- Primary completion
- Oct 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of IVACFLU-S in influenza, sponsored by Institute of Vaccines and Medical Biologicals. Started Mar 2017; status: completed.
02
Drugs
IVACFLU-S
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03095599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03095599.